ArisGlobal Introduces XDI Data Intelligence Cortex for Life Sciences

ArisGlobal has launched XDI, its new Data Intelligence Cortex, announced in a press release. The platform was introduced at the company’s Breakthrough 2026 event and is designed to transform regulated life sciences data into explainable, decision-grade intelligence across the entire product lifecycle.

XDI operates as a federated solution, bringing intelligence to data wherever it resides rather than consolidating it into a single system. It connects data signals across clinical, pharmacovigilance, regulatory, medical affairs, quality, and benefit-risk functions, enabling cross-domain reasoning that is both auditable and scalable.

The platform’s first offerings include operational intelligence for pharmacovigilance, benefit-risk management, and regulatory operations. Early evaluations indicate significant efficiency gains, such as up to 80% reduction in compliance effort and faster signal detection. XDI is built on ArisGlobal’s “Trust by Design” framework, which integrates AI governance, auditability, and regulatory compliance through its NavaX AI governance system.